Company Profile
CEO
Dr. Christopher S. Boerner Ph.D.(CEO & Chairman)
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
32.5K
Beta
0.24
Forward P/E
9.3
52W High
$62.89
52W Low
$42.52
Profit Margin
15.0%
Operating Margin
33.0%
Return on Equity
38.7%
Revenue Growth
2.6%
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience. The company's products include Opdivo for various anti-cancer indicat...
Valuation
Market Cap$113.48B
P/E (TTM)15.59
P/S (TTM)2.47
EV/EBITDA24.02
Cash Flow
FCF Yield+2.7%
SBC Adj. FCF Yield+2.2%
SBC Impact19.3%
Margins & Growth
Profit Margin23.3%
Operating Margin12.2%
Revenue YoY2.6%
Earnings YoY9.0%
Balance
Cash$9.57B
Debt$44.14B
Net Cash$-34.57B
Dividend
Dividend Yield4.52%
Payout Ratio47.9%
Quarterly Payout$1.28B